{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:49:34Z","timestamp":1795124974324,"version":"4.10.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Vellore Institute of Technology, Vellore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Uterine fibroids, though benign in nature, are burdensome tumors of the myometrium and continue to weigh heavily on the landscape of women\u2019s health. They affect millions and yet receive a fraction of the therapeutic innovation afforded to malignant diseases. Despite their prevalence, the molecular underpinnings of fibroid pathogenesis have long been met with a blind eye in drug development. Recent insights, however, reveal G-protein-coupled receptor 10 (GPR10) as a central driver of fibroid growth, promoting cell survival through the PI3K\/Akt and MAPK\/ERK signaling pathways following REST repression. In this study, we present a rigorous, computationally guided approach to design small interfering RNAs (siRNAs) that silence GPR10 expression at the transcriptomic level. Beginning with a library of 275 siRNA candidates, we undertook a layered in-silico refinement process, combining thermodynamic assessment, secondary structure modeling and off-target filtration, to distill a shortlist of ten high-confidence molecules. These were subjected to structural docking against Argonaute 2, the catalytic engine of the RNA-induced silencing complex, revealing siRNA8 and siRNA12 as lead candidates distinguished by robust binding affinity, high predicted silencing efficacy, which was greater than 93.5%, and precise conformational fit. Subsequent molecular dynamics simulations under CHARMM-GUI\/CHARMM36m force field, confirmed the structural stability and sustained silencing potential of the complex. Collectively, these findings identify GPR10 as a therapeutically actionable driver in fibroid biology and lay the groundwork for precision RNAi strategies targeting non-malignant, yet clinically neglected, hormone-dependent disorders.<\/jats:p>","DOI":"10.1038\/s41598-025-16936-z","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T07:12:05Z","timestamp":1756365125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Molecular dynamics simulations based siRNA design against GPR10 reveals stable RNAi therapeutics for hormone-dependent uterine fibroids"],"prefix":"10.1038","volume":"15","author":[{"given":"Srineevas","family":"Sriram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandresh","family":"Palanichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. T.","family":"Subash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manshi Kumari","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sudandiradoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"11","key":"16936_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/jwh.2015.5277","volume":"24","author":"DD Baird","year":"2015","unstructured":"Baird, D. D. et al. A prospective, Ultrasound-Based study to evaluate risk factors for uterine fibroid incidence and growth: methods and results of recruitment. J. Women S Health. 24 (11), 907\u2013915. https:\/\/doi.org\/10.1089\/jwh.2015.5277 (2015).","journal-title":"J. Women S Health"},{"issue":"8","key":"16936_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1089\/jwh.2005.14.692","volume":"14","author":"J Mauskopf","year":"2005","unstructured":"Mauskopf, J., Flynn, M., Thieda, P., Spalding, J. & Duchane, J. The economic impact of uterine fibroids in the united states: A summary of published estimates. J. Women S Health. 14 (8), 692\u2013703. https:\/\/doi.org\/10.1089\/jwh.2005.14.692 (2005).","journal-title":"J. Women S Health"},{"issue":"14","key":"16936_CR3","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1056\/nejmra1209993","volume":"369","author":"SE Bulun","year":"2013","unstructured":"Bulun, S. E. Uterine fibroids. N. Engl. J. Med. 369 (14), 1344\u20131355. https:\/\/doi.org\/10.1056\/nejmra1209993 (2013).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"16936_CR4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1073\/pnas.1215759110","volume":"110","author":"BV Varghese","year":"2013","unstructured":"Varghese, B. V. et al. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of Rapamycin pathway. Proc. Natl. Acad. Sci. 110 (6), 2187\u20132192. https:\/\/doi.org\/10.1073\/pnas.1215759110 (2013).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"16936_CR5","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.fertnstert.2014.07.017","volume":"102","author":"F Koohestani","year":"2014","unstructured":"Koohestani, F., McWilliams, M., Wertenberger, R. & Chennathukuzhi, V. WNT and mTOR pathways in the G-protein coupled receptor 10 (GPR10) Transgenic mouse model of uterine fibroids. Fertil. Steril. 102 (3), e3. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.07.017 (2014).","journal-title":"Fertil. Steril."},{"key":"16936_CR6","doi-asserted-by":"publisher","unstructured":"Falzone, M. E. & MacKinnon, R. The mechanism of G\u03b1 q regulation of PLC\u03b23 -catalyzed PIP2 hydrolysis. Proceedings of the National Academy of Sciences, 120(48). (2023). https:\/\/doi.org\/10.1073\/pnas.2315011120","DOI":"10.1073\/pnas.2315011120"},{"issue":"9","key":"16936_CR7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.peptides.2011.08.011","volume":"32","author":"L Malet\u00ednsk\u00e1","year":"2011","unstructured":"Malet\u00ednsk\u00e1, L., \u0160polcov\u00e1, A., Maixnerov\u00e1, J., Blechov\u00e1, M. & \u017delezn\u00e1, B. Biological properties of prolactin-releasing peptide analogs with a modified aromatic ring of a C-terminal phenylalanine amide. Peptides 32 (9), 1887\u20131892. https:\/\/doi.org\/10.1016\/j.peptides.2011.08.011 (2011).","journal-title":"Peptides"},{"issue":"4","key":"16936_CR8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.peptides.2010.12.011","volume":"32","author":"J Maixnerov\u00e1","year":"2010","unstructured":"Maixnerov\u00e1, J. et al. Characterization of prolactin-releasing peptide: binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor. Peptides 32 (4), 811\u2013817. https:\/\/doi.org\/10.1016\/j.peptides.2010.12.011 (2010).","journal-title":"Peptides"},{"issue":"8","key":"16936_CR9","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.fertnstert.2009.03.100","volume":"93","author":"L Karra","year":"2009","unstructured":"Karra, L. et al. Changes related to phosphatidylinositol 3-kinase\/Akt signaling in leiomyomas: possible involvement of glycogen synthase kinase 3\u03b1 and Cyclin D2 in the pathophysiology. Fertil. Steril. 93 (8), 2646\u20132651. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.100 (2009).","journal-title":"Fertil. Steril."},{"issue":"1\u20132","key":"16936_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1385\/jmn:22:1-2:93","volume":"22","author":"W Gu","year":"2004","unstructured":"Gu, W., Geddes, B. J., Zhang, C., Foley, K. P. & Stricker-Krongrad, A. The Prolactin-Releasing peptide receptor (GPR10) regulates body weight homeostasis in mice. J. Mol. Neurosci. 22 (1\u20132), 93\u2013104. https:\/\/doi.org\/10.1385\/jmn:22:1-2:93 (2004).","journal-title":"J. Mol. Neurosci."},{"issue":"5","key":"16936_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.peptides.2006.01.008","volume":"27","author":"WK Samson","year":"2006","unstructured":"Samson, W. K. & Taylor, M. M. Prolactin releasing peptide (PrRP): an endogenous regulator of cell growth. Peptides 27 (5), 1099\u20131103. https:\/\/doi.org\/10.1016\/j.peptides.2006.01.008 (2006).","journal-title":"Peptides"},{"key":"16936_CR12","doi-asserted-by":"publisher","unstructured":"Cloud, A. S. et al. Loss of the repressor REST affects progesterone receptor function and promotes uterine leiomyoma pathogenesis. Proc. Natl. Acad. Sci. 119 (44). https:\/\/doi.org\/10.1073\/pnas.2205524119 (2022).","DOI":"10.1073\/pnas.2205524119"},{"issue":"3","key":"16936_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nrg2006","volume":"8","author":"DH Kim","year":"2007","unstructured":"Kim, D. H. & Rossi, J. J. Strategies for Silencing human disease using RNA interference. Nat. Rev. Genet. 8 (3), 173\u2013184. https:\/\/doi.org\/10.1038\/nrg2006 (2007).","journal-title":"Nat. Rev. Genet."},{"issue":"6836","key":"16936_CR14","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 (6836), 494\u2013498. https:\/\/doi.org\/10.1038\/35078107 (2001).","journal-title":"Nature"},{"issue":"2","key":"16936_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.59566\/ijbs.2017.13048","volume":"13","author":"H Dana","year":"2017","unstructured":"Dana, H. et al. Molecular mechanisms and biological functions of SiRNA. Int. J. Biomedical Sci. 13 (2), 48\u201357. https:\/\/doi.org\/10.59566\/ijbs.2017.13048 (2017).","journal-title":"Int. J. Biomedical Sci."},{"issue":"11","key":"16936_CR16","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.4161\/cbt.3.11.1309","volume":"3","author":"TC Karagiannis","year":"2004","unstructured":"Karagiannis, T. C. & El-Osta, A. SiRNAs: mechanism of RNA interference, in vivo and potential clinical applications. Cancer Biol. Ther. 3 (11), 1069\u20131074. https:\/\/doi.org\/10.4161\/cbt.3.11.1309 (2004).","journal-title":"Cancer Biol. Ther."},{"key":"16936_CR17","doi-asserted-by":"publisher","first-page":"7605","DOI":"10.2147\/ijn.s436038","volume":"18","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. A comprehensive review of small interfering RNAs (SiRNAs): mechanism, therapeutic targets, and delivery strategies for cancer therapy. Int. J. Nanomed. 18, 7605\u20137635. https:\/\/doi.org\/10.2147\/ijn.s436038 (2023).","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"16936_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nrg2968","volume":"12","author":"BL Davidson","year":"2011","unstructured":"Davidson, B. L. & McCray, P. B. Current prospects for RNA interference-based therapies. Nat. Rev. Genet. 12 (5), 329\u2013340. https:\/\/doi.org\/10.1038\/nrg2968 (2011).","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"16936_CR19","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/nmat3765","volume":"12","author":"R Kanasty","year":"2013","unstructured":"Kanasty, R., Dorkin, J. R., Vegas, A. & Anderson, D. Delivery materials for SiRNA therapeutics. Nat. Mater. 12 (11), 967\u2013977. https:\/\/doi.org\/10.1038\/nmat3765 (2013).","journal-title":"Nat. Mater."},{"issue":"1","key":"16936_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrd3010","volume":"9","author":"AL Jackson","year":"2009","unstructured":"Jackson, A. L. & Linsley, P. S. Recognizing and avoiding SiRNA off-target effects for target identification and therapeutic application. Nat. Rev. Drug Discovery. 9 (1), 57\u201367. https:\/\/doi.org\/10.1038\/nrd3010 (2009).","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"2","key":"16936_CR21","doi-asserted-by":"publisher","first-page":"102195","DOI":"10.1016\/j.omtn.2024.102195","volume":"35","author":"W Yuan","year":"2024","unstructured":"Yuan, W., Shi, X. & Lee, L. T. O. RNA therapeutics in targeting G protein-coupled receptors: recent advances and challenges. Mol. Therapy Nucleic Acids. 35 (2), 102195. https:\/\/doi.org\/10.1016\/j.omtn.2024.102195 (2024).","journal-title":"Mol. Therapy Nucleic Acids"},{"issue":"D1","key":"16936_CR22","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1093\/nar\/gkae979","volume":"53","author":"EW Sayers","year":"2024","unstructured":"Sayers, E. W. et al. Database resources of the National center for biotechnology information in 2025. Nucleic Acids Res. 53 (D1), D20\u2013D29. https:\/\/doi.org\/10.1093\/nar\/gkae979 (2024).","journal-title":"Nucleic Acids Res."},{"issue":"7873","key":"16936_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with alphafold. Nature 596 (7873), 583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2 (2021).","journal-title":"Nature"},{"issue":"D1","key":"16936_CR24","doi-asserted-by":"publisher","first-page":"D368","DOI":"10.1093\/nar\/gkad1011","volume":"52","author":"M Varadi","year":"2023","unstructured":"Varadi, M. et al. AlphaFold protein structure database in 2024: providing structure coverage for over 214 million protein sequences. Nucleic Acids Res. 52 (D1), D368\u2013D375. https:\/\/doi.org\/10.1093\/nar\/gkad1011 (2023).","journal-title":"Nucleic Acids Res."},{"key":"16936_CR25","doi-asserted-by":"publisher","unstructured":"Schirle, N. T. & MacRae, I. J. The crystal structure of human argonaute2. (2012). https:\/\/doi.org\/10.2210\/pdb4OLA\/pdb","DOI":"10.2210\/pdb4OLA\/pdb"},{"issue":"6084","key":"16936_CR26","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1126\/science.1221551","volume":"336","author":"NT Schirle","year":"2012","unstructured":"Schirle, N. T. & MacRae, I. J. The crystal structure of human argonaute2. Science 336 (6084), 1037\u20131040. https:\/\/doi.org\/10.1126\/science.1221551 (2012).","journal-title":"Science"},{"key":"16936_CR27","doi-asserted-by":"publisher","unstructured":"Naito, Y., Yoshimura, J., Morishita, S. & Ui-Tei, K. SiDirect 2.0: updated software for designing functional SiRNA with reduced seed-dependent off-target effect. BMC Bioinform. 10 (1). https:\/\/doi.org\/10.1186\/1471-2105-10-392 (2009).","DOI":"10.1186\/1471-2105-10-392"},{"issue":"3","key":"16936_CR28","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/nar\/gkh247","volume":"32","author":"K Ui-Tei","year":"2004","unstructured":"Ui-Tei, K. et al. Guidelines for the selection of highly effective SiRNA sequences for mammalian and chick RNA interference. Nucleic Acids Res. 32 (3), 936\u2013948. https:\/\/doi.org\/10.1093\/nar\/gkh247 (2004).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"16936_CR29","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nbt936","volume":"22","author":"A Reynolds","year":"2004","unstructured":"Reynolds, A. et al. Rational SiRNA design for RNA interference. Nat. Biotechnol. 22 (3), 326\u2013330. https:\/\/doi.org\/10.1038\/nbt936 (2004).","journal-title":"Nat. Biotechnol."},{"issue":"4","key":"16936_CR30","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.bbrc.2004.02.157","volume":"316","author":"M Amarzguioui","year":"2004","unstructured":"Amarzguioui, M. & Prydz, H. An algorithm for selection of functional SiRNA sequences. Biochem. Biophys. Res. Commun. 316 (4), 1050\u20131058. https:\/\/doi.org\/10.1016\/j.bbrc.2004.02.157 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"22","key":"16936_CR31","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1093\/nar\/gkn902","volume":"36","author":"K Ui-Tei","year":"2008","unstructured":"Ui-Tei, K., Naito, Y., Nishi, K., Juni, A. & Saigo, K. Thermodynamic stability and Watson-Crick base pairing in the seed duplex are major determinants of the efficiency of the siRNA-based off-target effect. Nucleic Acids Res. 36 (22), 7100\u20137109. https:\/\/doi.org\/10.1093\/nar\/gkn902 (2008).","journal-title":"Nucleic Acids Res."},{"key":"16936_CR32","doi-asserted-by":"publisher","unstructured":"Reuter, J. S. & Mathews, D. H. RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinform. 11 (1). https:\/\/doi.org\/10.1186\/1471-2105-11-129 (2010).","DOI":"10.1186\/1471-2105-11-129"},{"issue":"13","key":"16936_CR33","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1093\/nar\/gkg595","volume":"31","author":"M Zuker","year":"2003","unstructured":"Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (13), 3406\u20133415. https:\/\/doi.org\/10.1093\/nar\/gkg595 (2003).","journal-title":"Nucleic Acids Res."},{"key":"16936_CR34","doi-asserted-by":"publisher","unstructured":"Markham, N. R. & Zuker, M. DINAMelt web server for nucleic acid melting prediction. Nucleic Acids Res. 33 https:\/\/doi.org\/10.1093\/nar\/gki591 (2005). Web ServerW577-W581.","DOI":"10.1093\/nar\/gki591"},{"key":"16936_CR35","doi-asserted-by":"publisher","unstructured":"Kibbe, W. A. OligoCalc: an online oligonucleotide properties calculator. Nucleic Acids Res. 35 (Web Server). https:\/\/doi.org\/10.1093\/nar\/gkm234 (2007). W43-W46.","DOI":"10.1093\/nar\/gkm234"},{"key":"16936_CR36","doi-asserted-by":"publisher","unstructured":"Lu, Z. J. & Mathews, D. H. OligoWalk: an online SiRNA design tool utilizing hybridization thermodynamics. Nucleic Acids Res. 36 https:\/\/doi.org\/10.1093\/nar\/gkn250 (2008). Web ServerW104-W108.","DOI":"10.1093\/nar\/gkn250"},{"issue":"5","key":"16936_CR37","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Tao, H., He, J. & Huang, S. The HDOCK server for integrated protein-protein Docking. Nat. Protoc. 15 (5), 1829\u20131852. https:\/\/doi.org\/10.1038\/s41596-020-0312-x (2020).","journal-title":"Nat. Protoc."},{"key":"16936_CR38","unstructured":"Schr\u00f6dinger. PYMOL | Schr\u00f6dinger. Schr\u00f6dinger. (2025)., April 22 https:\/\/www.schrodinger.com\/platform\/products\/pymol\/"},{"key":"16936_CR39","doi-asserted-by":"publisher","unstructured":"Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1\u20132, 19\u201325. (2015). https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","DOI":"10.1016\/j.softx.2015.06.001"},{"key":"16936_CR40","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.5c00194","author":"A Paladino","year":"2025","unstructured":"Paladino, A., Catte, A., Franco, J., Moroni, E. & Rinaldi, S. Conformational dynamics of hAgo2 silencing: decoding functional divergence across human argonaute paralogs. J. Chem. Inf. Model. https:\/\/doi.org\/10.1021\/acs.jcim.5c00194 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"16936_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8792814","volume":"2016","author":"V Bhandare","year":"2016","unstructured":"Bhandare, V. & Ramaswamy, A. Structural dynamics of human Argonaute2 and its interaction with SiRNAs designed to target mutant tdp43. Adv. Bioinf. 2016, 1\u201313. https:\/\/doi.org\/10.1155\/2016\/8792814 (2016).","journal-title":"Adv. Bioinf."},{"issue":"3","key":"16936_CR42","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/nar\/gks1191","volume":"41","author":"S Sciabola","year":"2012","unstructured":"Sciabola, S., Cao, Q., Orozco, M., Faustino, I. & Stanton, R. V. Improved nucleic acid descriptors for SiRNA efficacy prediction. Nucleic Acids Res. 41 (3), 1383\u20131394. https:\/\/doi.org\/10.1093\/nar\/gks1191 (2012).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"16936_CR43","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cell.2012.05.017","volume":"150","author":"E Elkayam","year":"2012","unstructured":"Elkayam, E. et al. The structure of human Argonaute-2 in complex with miR-20a. Cell 150 (1), 100\u2013110. https:\/\/doi.org\/10.1016\/j.cell.2012.05.017 (2012).","journal-title":"Cell"},{"key":"16936_CR44","doi-asserted-by":"publisher","unstructured":"Lessel, D. et al. Germline AGO2 mutations impair RNA interference and human neurological development. Nat. Commun. 11 (1). https:\/\/doi.org\/10.1038\/s41467-020-19572-5 (2020).","DOI":"10.1038\/s41467-020-19572-5"},{"key":"16936_CR45","doi-asserted-by":"publisher","unstructured":"Imanpour, A. et al. In Silico engineering and simulation of RNA interferences nanoplatforms for osteoporosis treating and bone healing promoting. Sci. Rep. 13 (1). https:\/\/doi.org\/10.1038\/s41598-023-45183-3 (2023).","DOI":"10.1038\/s41598-023-45183-3"},{"issue":"12","key":"16936_CR46","doi-asserted-by":"publisher","first-page":"19915","DOI":"10.1002\/jcb.29300","volume":"120","author":"B Mallick","year":"2019","unstructured":"Mallick, B., Sharma, A. R., Lee, S. & Chakraborty, C. Understanding the molecular interaction of human argonaute-2 and miR\u201020a complex: A molecular dynamics approach. J. Cell. Biochem. 120 (12), 19915\u201319924. https:\/\/doi.org\/10.1002\/jcb.29300 (2019).","journal-title":"J. Cell. Biochem."},{"key":"16936_CR47","doi-asserted-by":"publisher","first-page":"105310","DOI":"10.1016\/j.meegid.2022.105310","volume":"102","author":"A Mahfuz","year":"2022","unstructured":"Mahfuz, A. et al. Designing potential SiRNA molecules for Silencing the gene of the nucleocapsid protein of Nipah virus: A computational investigation. Infect. Genet. Evol. 102, 105310. https:\/\/doi.org\/10.1016\/j.meegid.2022.105310 (2022).","journal-title":"Infect. Genet. Evol."},{"key":"16936_CR48","doi-asserted-by":"publisher","unstructured":"Kakoulidis, P. et al. Comparative structural insights and functional analysis for the distinct unbound States of human AGO proteins. Sci. Rep. 15 (1). https:\/\/doi.org\/10.1038\/s41598-025-91849-5 (2025).","DOI":"10.1038\/s41598-025-91849-5"},{"key":"16936_CR49","doi-asserted-by":"publisher","first-page":"107687","DOI":"10.1016\/j.compbiolchem.2022.107687","volume":"98","author":"P Madanagopal","year":"2022","unstructured":"Madanagopal, P., Muthukumar, H. & Thiruvengadam, K. Computational study and design of effective SiRNAs to silence structural proteins associated genes of Indian SARS-CoV-2 strains. Comput. Biol. Chem. 98, 107687. https:\/\/doi.org\/10.1016\/j.compbiolchem.2022.107687 (2022).","journal-title":"Comput. Biol. Chem."},{"key":"16936_CR50","doi-asserted-by":"publisher","unstructured":"Ramalingam, P. S. & Arumugam, S. Computational design and validation of effective SiRNAs to silence oncogenic KRAS. 3 Biotech. 13 (11). https:\/\/doi.org\/10.1007\/s13205-023-03767-w (2023).","DOI":"10.1007\/s13205-023-03767-w"},{"issue":"10","key":"16936_CR51","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1261\/rna.1643609","volume":"15","author":"ZJ Lu","year":"2009","unstructured":"Lu, Z. J., Gloor, J. W. & Mathews, D. H. Improved RNA secondary structure prediction by maximizing expected pair accuracy. RNA 15 (10), 1805\u20131813. https:\/\/doi.org\/10.1261\/rna.1643609 (2009).","journal-title":"RNA"},{"key":"16936_CR52","doi-asserted-by":"publisher","unstructured":"Markham, N. R. & Zuker, M. UNAFold. Methods in Molecular Biology, 3\u201331. (2008). https:\/\/doi.org\/10.1007\/978-1-60327-429-6_1","DOI":"10.1007\/978-1-60327-429-6_1"},{"issue":"1","key":"16936_CR53","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2015","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, openmm, and charmm\/openmm simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12 (1), 405\u2013413. https:\/\/doi.org\/10.1021\/acs.jctc.5b00935 (2015).","journal-title":"J. Chem. Theory Comput."},{"issue":"10","key":"16936_CR54","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","volume":"30","author":"BR Brooks","year":"2009","unstructured":"Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 30 (10), 1545\u20131614. https:\/\/doi.org\/10.1002\/jcc.21287 (2009).","journal-title":"J. Comput. Chem."},{"issue":"11","key":"16936_CR55","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: A web\u2010based graphical user interface for CHARMM. J. Comput. Chem. 29 (11), 1859\u20131865. https:\/\/doi.org\/10.1002\/jcc.20945 (2008).","journal-title":"J. Comput. Chem."},{"key":"16936_CR56","doi-asserted-by":"publisher","unstructured":"Zaidi, S. S. A. et al. Engineering SiRNA therapeutics: challenges and strategies. J. Nanobiotechnol. 21 (1). https:\/\/doi.org\/10.1186\/s12951-023-02147-z (2023).","DOI":"10.1186\/s12951-023-02147-z"},{"issue":"5","key":"16936_CR57","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","volume":"23","author":"K Paunovska","year":"2022","unstructured":"Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23 (5), 265\u2013280. https:\/\/doi.org\/10.1038\/s41576-021-00439-4 (2022).","journal-title":"Nat. Rev. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16936-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16936-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16936-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T19:02:44Z","timestamp":1756753364000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16936-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16936"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16936-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"There are no potential conflicts of interest to declare by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"31708"}}